東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

From imitation to innovation: The r...

Li, Yahong.

Linked to FindBook

Google Book

Amazon

博客來

From imitation to innovation: The role of patent in China's biotechnology and pharmaceutical industries.

Record Type:	Language materials, printed : Monograph/item
Title/Author:	From imitation to innovation: The role of patent in China's biotechnology and pharmaceutical industries./
Author:	Li, Yahong.
Description:	132 p.
Notes:	Adviser: John H. Barton.
Contained By:	Dissertation Abstracts International68-09A.
Subject:	Chemistry, Pharmaceutical. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3281884
ISBN:	9780549244561

From imitation to innovation: The role of patent in China's biotechnology and pharmaceutical industries.
Li, Yahong.

From imitation to innovation: The role of patent in China's biotechnology and pharmaceutical industries. - 132 p.

Adviser: John H. Barton.

Thesis (J.S.D.)--Stanford University, 2007.

China has set a national goal to advance itself from an "imitation-oriented country" to an "innovation-oriented country" by year 2020, and is aiming to rank top five in the world in the annual granted indigenous invention patents, in order to achieve this goal. The question is whether more patents mean more innovations, and whether China's current patent regime is appropriate for promoting innovation? This dissertation uses the interplay between patent and biotechnology and pharmaceutical industries in China as a case study to answer this question. The dissertation found that, compared with the developed countries, although fairly advanced in the selected areas, China's biotech and pharmaceutical industries as a whole still lags behind. A strong patent system is still indispensable for stimulating innovation in China. The problem of access to technology and medicine is not caused by patent system, but by the monopoly of multinational pharmaceutical companies and by the irregular and immature Chinese drug market. Other laws such as anti-trust law may be an answer to this problem. While it is important to balance interests between patent right protection and public welfare, transforming China from an "imitation-oriented country" to an "innovation-oriented country" should be the government's top priority. To accomplish this goal, patent law still has much room to improve and a greater role to play.

ISBN: 9780549244561Subjects--Topical Terms:

550957
Chemistry, Pharmaceutical.

From imitation to innovation: The role of patent in China's biotechnology and pharmaceutical industries.
LDR:02325nam 2200277 a 45 001 955640
005 20110622
008 110622s2007 ||||||||||||||||| ||eng d
020 $a 9780549244561
035 $a (UMI)AAI3281884
035 $a AAI3281884
040 $a UMI $c UMI
100 1 $a Li, Yahong. $3 1279101
245 1 0 $a From imitation to innovation: The role of patent in China's biotechnology and pharmaceutical industries.
300 $a 132 p.
500 $a Adviser: John H. Barton.
500 $a Source: Dissertation Abstracts International, Volume: 68-09, Section: A, page: 4044.
502 $a Thesis (J.S.D.)--Stanford University, 2007.
520 $a China has set a national goal to advance itself from an "imitation-oriented country" to an "innovation-oriented country" by year 2020, and is aiming to rank top five in the world in the annual granted indigenous invention patents, in order to achieve this goal. The question is whether more patents mean more innovations, and whether China's current patent regime is appropriate for promoting innovation? This dissertation uses the interplay between patent and biotechnology and pharmaceutical industries in China as a case study to answer this question. The dissertation found that, compared with the developed countries, although fairly advanced in the selected areas, China's biotech and pharmaceutical industries as a whole still lags behind. A strong patent system is still indispensable for stimulating innovation in China. The problem of access to technology and medicine is not caused by patent system, but by the monopoly of multinational pharmaceutical companies and by the irregular and immature Chinese drug market. Other laws such as anti-trust law may be an answer to this problem. While it is important to balance interests between patent right protection and public welfare, transforming China from an "imitation-oriented country" to an "innovation-oriented country" should be the government's top priority. To accomplish this goal, patent law still has much room to improve and a greater role to play.
590 $a School code: 0212.
650 4 $a Chemistry, Pharmaceutical. $3 550957
650 4 $a Law. $3 600858
690 $a 0398
690 $a 0491
710 2 $a Stanford University. $3 754827
773 0 $t Dissertation Abstracts International $g 68-09A.
790 $a 0212
790 1 0 $a Barton, John H., $e advisor
791 $a J.S.D.
792 $a 2007
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3281884